日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study

瑞戈非尼单药治疗RAS突变型晚期结直肠癌患者二线治疗(STREAM):一项学术性、多中心、单臂、两阶段II期研究

Cardone, C; De Stefano, A; Rosati, G; Cassata, A; Silvestro, L; Borrelli, M; Di Gennaro, E; Romano, C; Nappi, A; Zanaletti, N; Foschini, F; Casaretti, R; Tatangelo, F; Lastoria, S; Raddi, M; Bilancia, D; Granata, V; Setola, S; Petrillo, A; Vitagliano, C; Gargiulo, P; Arenare, L; Febbraro, A; Martinelli, E; Ciardiello, F; Delrio, P; Budillon, A; Piccirillo, M C; Avallone, A

Reduction of GPSM3 expression akin to the arthritis-protective SNP rs204989 differentially affects migration in a neutrophil model

与关节炎保护性 SNP rs204989 类似的 GPSM3 表达减少对中性粒细胞模型中的迁移产生不同的影响

B J Gall, A B Schroer, J D Gross, V Setola, D P Siderovski